FGFR1 is also implicated in a higher risk of distant metastasis and chemo-resistance of various cancer (Cao et al., 2017; Jang et al., 2017), such as malignant lymphoma (Cao et al., 2014), breast cancer (Turner et al., 2010; Golfmann et al., 2018), and gastric cancer (Chen et al., 2014; Schafer et al., 2015; Shimizu et al., 2018). This evidence concerns the gene FGFR1 and gastric cancer.